Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2025-12-24 @ 1:16 PM
NCT ID:
NCT02454595
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed (\< or equal to 12 months), untreated patients with histologically proven adenocarcinoma of the prostate that have the following characteristics:
* PSA less than or equal to 10 ng/dl and
* Gleason's 7 (4+3 or 3+4) or Gleason's 6 and
* Age greater than 55 years old and
* Clinical Stage T1 or T2
* Clinically localized (no evidence on clinical or imaging studies of advanced disease).
* No hormonal therapy including luteinizing hormone-releasing hormone (LHRH) agonist or antagonist, anti-androgen, estrogens or exogenous androgens, when applicable.
Exclusion Criteria:
\- Known history of hypogonadism
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
55 Years
Study:
NCT02454595
Study Brief:
Protocol Section:
NCT02454595